Limbach Gruppe offer more than 200 established clinical markers for targeted diagnosis of systemic and organ-specific autoimmune diseases. We continually expand our portfolio, adding new medically relevant target antigens and diagnostic autoantibodies. Given the vast number of available markers, it is particularly important to choose suitable test systems and ensure skilled result assessment. Our experts at Limbach Gruppe will provide customised assistance to ensure a rational and systematic diagnostic approach.